Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper B Hansen

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Biological Chemistry|November 25, 2022
<i>In vitro</i> ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugsElena Bechthold, Lucie Grey, Emil Diamant, et al.
Neuropharmacology|January 29, 2020
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunitsFeng Yi, Nirvan Rouzbeh, Kasper B Hansen, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
Molecular Pharmacology|September 1, 2005
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesisKasper B Hansen, Rasmus P Clausen, Esben J Bjerrum, et al.
Molecular Pharmacology|February 7, 2025
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecular Pharmacology|November 5, 2024
Evaluation of allosteric NMDA receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Journal of Medicinal Chemistry|February 12, 2014
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiatorsSommer S Zimmerman, Alpa Khatri, Ethel C Garnier-Amblard, et al.
The Journal of Biological Chemistry|November 7, 2009
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporterJacob Andersen, Lars Olsen, Kasper B Hansen, et al.
Journal of Medicinal Chemistry|March 5, 2015
Correction to "Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators"Sommer S Zimmerman, Alpa Khatri, Ethel C Garnier-Amblard, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Biological Chemistry|November 25, 2022
<i>In vitro</i> ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugsElena Bechthold, Lucie Grey, Emil Diamant, et al.
Neuropharmacology|January 29, 2020
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunitsFeng Yi, Nirvan Rouzbeh, Kasper B Hansen, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
Molecular Pharmacology|September 1, 2005
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesisKasper B Hansen, Rasmus P Clausen, Esben J Bjerrum, et al.
Molecular Pharmacology|February 7, 2025
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecular Pharmacology|November 5, 2024
Evaluation of allosteric NMDA receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Journal of Medicinal Chemistry|February 12, 2014
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiatorsSommer S Zimmerman, Alpa Khatri, Ethel C Garnier-Amblard, et al.
The Journal of Biological Chemistry|November 7, 2009
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporterJacob Andersen, Lars Olsen, Kasper B Hansen, et al.
Journal of Medicinal Chemistry|March 5, 2015
Correction to "Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators"Sommer S Zimmerman, Alpa Khatri, Ethel C Garnier-Amblard, et al.
Pageof 9